Inventive, curious, and committed to results? We’re hiring.Explore Job Opportunities
We’re dedicated to decarbonizing the global inhaler market and committed to leading the transition to the next generation of green propellants. Our low-GWP formulations will be easier on the environment while delivering performance patients can trust.
pMDIs are responsible for 3% of global emissions in the UK.* At Kindeva, we’re on a mission to change that. Our passion for innovation is matched by a track record of leadership in sustainability.
by Louise Righton, Global Strategic Marketing Leader, Inhaled Drug Delivery
A study authored by Frontier Economics and provided during the PCRS Respiratory Conference 2021. For additional details, click here.
* NHS England and NHS Improvement, Delivering a ‘Net Zero’ National Health Service (London: Skipton House, 2020)
We will lead the industry’s transition to greener gasses just as we led the transition from CFC- to HFA-based inhalers in the 1990s, developing the world’s first CFC-free pMDI and the world’s first CFC-free nasal pMDI.
Need an expert to bring you from promise to production? We want to be your CDMO of choice.